Surgery in a pill
Location: United States
Employees: 1-10
Total raised: $5M
Founded date: 2019
Investors 7
Funding Rounds 1
| Date | Series | Amount | Investors |
| 17.09.2025 | Series A | $5M | - |
Mentions in press and media 2
| Date | Title | Description |
| 17.09.2025 | AltrixBio: $5 Million Series A Closed For Developing Cardiometabolic Disease Treatment | AltrixBio has secured $5 million in an initial Series A financing to advance its lead candidate, AJN 003 (LuCI), into human clinical trials for type 2 diabetes and related metabolic diseases. This oral therapy is designed to recreate the me... |
| - | AltrixBio | “AJN 003 (LuCI™) by AltrixBio delivers the life-changing metabolic effects of bariatric surgery in a once-daily pill. Learn how our breakthrough oral therapy is redefining treatment for type 2 diabetes and obesity without surgery, injection... |